Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04852224 · ClinicalTrials.gov registry record
Strength, Aging, and Memory in Prostate Cancer
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 20
- Enrollment target
NCT04852224 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 20 participants.
The verdict
NCT04852224 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The objective of this study is to compare changes in neurocognitive function across a 12-month period between three groups: (1) men treated with androgen deprivation therapy (ADT) for prostate cancer (PCa); (2) men under active surveillance for PCa; and (3) men without a history of cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-10-01 |
| Est. Completion | 2023-04-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04852224
The ClinicalTrials.gov registry entry for NCT04852224 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04852224 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04852224 about?
NCT04852224 is a clinical study titled "Strength, Aging, and Memory in Prostate Cancer". The objective of this study is to compare changes in neurocognitive function across a 12-month period between three groups: (1) men treated with androgen deprivation therapy (ADT) for prostate cancer (PCa); (2) men under active surveillance for PCa; and (3) men without a history of cancer.
What is the current status of trial NCT04852224?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2021-10-01. Estimated completion is 2023-04-26.
Who is sponsoring clinical trial NCT04852224?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.